S3N (p.Ser3Asn) variant of MYCN (N-myc proto-oncogene protein)

S3N (p.Ser3Asn) in MYCN (N-myc proto-oncogene protein) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data and structural context.

S3N (p.Ser3Asn) variant details